J 2023

Serum matrix metalloproteinase-9 (MMP-9) as a biomarker in paediatric and adult tick-borne encephalitis patients.

FOŘTOVÁ, Andrea, Václav HÖNIG, Jiří SALÁT, Martin PALUS, Martina PÝCHOVÁ et. al.

Základní údaje

Originální název

Serum matrix metalloproteinase-9 (MMP-9) as a biomarker in paediatric and adult tick-borne encephalitis patients.

Autoři

FOŘTOVÁ, Andrea (203 Česká republika), Václav HÖNIG (203 Česká republika), Jiří SALÁT (203 Česká republika), Martin PALUS (203 Česká republika), Martina PÝCHOVÁ (203 Česká republika, domácí), Lenka KRBKOVÁ (203 Česká republika, domácí), Andrey V. BARKHASH, Michal F. KRIHA, Ales CHRDLE, Marie LIPOLDOVA a Daniel RŮŽEK (203 Česká republika, garant, domácí)

Vydání

Virus Research, Elsevier, 2023, 0168-1702

Další údaje

Jazyk

angličtina

Typ výsledku

Článek v odborném periodiku

Obor

10607 Virology

Stát vydavatele

Nizozemské království

Utajení

není předmětem státního či obchodního tajemství

Odkazy

Impakt faktor

Impact factor: 5.000 v roce 2022

Kód RIV

RIV/00216224:14310/23:00130311

Organizační jednotka

Přírodovědecká fakulta

UT WoS

000920459100001

Klíčová slova anglicky

Tick-borne encephalitis; Neuroinfection; Matrix matalloproteinase; Cerebrospinal fluid

Štítky

Příznaky

Mezinárodní význam, Recenzováno
Změněno: 2. 3. 2023 12:35, Mgr. Marie Šípková, DiS.

Anotace

V originále

Matrix metalloproteinases (MMPs) play an important role in central nervous system infections. We analysed the levels of 8 different MMPs in the cerebrospinal fluid (CSF) of 89 adult patients infected with tick-borne encephalitis (TBE) virus and compared them with the levels in a control group. MMP-9 was the only MMP that showed significantly increased CSF levels in TBE patients. Serum MMP-9 levels were subsequently measured in 101 adult TBE patients at various time points during the neurological phase of TBE and at follow-up. In addition, serum MMP-9 was analysed in 37 paediatric TBE patients. Compared with control levels, both paediatric and adult TBE patients had significantly elevated serum MMP-9 levels. In most adult patients, serum MMP-9 levels peaked at hospital admission, with higher serum MMP-9 levels observed in patients with encephalitis than in patients with meningitis. Elevated serum MMP-9 levels were observed throughout hospitalisation but decreased to normal levels at follow-up. Serum MMP-9 levels correlated with clinical course, especially in patients heterozygous for the single-nucleotide polymorphism rs17576 (A/G; Gln279Arg) in the MMP9 gene. The results highlight the importance of MMP-9 in the pathogenesis of TBE and suggest that serum MMP-9 may serve as a promising bioindicator of TBE in both paediatric and adult TBE patients.